Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.490
+0.110 (7.97%)
Mar 9, 2026, 2:51 PM EDT - Market open
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $24.84 million as of March 9, 2026. Its market cap has increased by 71.33% in one year.
Market Cap
24.84M
Enterprise Value
5.42M
1-Year Change
71.33%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $24.84M, a decrease of -45.76%. That is a compound annual growth rate of -6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 23.00M | -7.26% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 25.37M |
| Boundless Bio | 25.29M |
| Barinthus Biotherapeutics | 24.62M |
| Vistagen Therapeutics | 24.08M |
| Neuphoria Therapeutics | 23.29M |
| Skye Bioscience | 23.09M |
| Daré Bioscience | 21.86M |
| IO Biotech | 21.62M |